Antibiotic kit and composition and uses thereof
DCFirst Claim
1. A method of treating or alleviating disorders of a skin, body cavity or mucosal surface, wherein the disorder involves inflammation as one of its etiological factors, the method comprising:
- a. releasing a foamable composition from an aerosol container to form an expanded thermally stable foam that collapses upon application of mechanical force, said foamable composition comprising a propellant and a composition, said composition comprising;
i. an antibiotic agent;
ii. a therapeutically active oil comprising about 10% to about 50% by weight of the composition of a capric/caprylic triglyceride;
iii. a surface-active agent;
iv. about 0.01% to about 5% by weight of the composition of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent; and
v. water;
wherein the propellant comprises a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the foamable compositionb. administering the foam to a target area having a disorder of the skin, body cavity or mucosa; and
c. collapsing the foam by applying mechanical force, wherein the foam is absorbed onto the target area,wherein the antibiotic agent is administered in a therapeutically effective amount;
wherein the composition contains less than 5% by weight of the composition of short chain alcohols having up to 5 carbon atoms in their carbon chain skeleton and one hydroxyl group; and
wherein the composition is a thermally stable breakable foam.
8 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention relates to a therapeutic kit to provide a safe and effective dosage of an antibiotic agent, including an aerosol packaging assembly including: a container accommodating a pressurized product; and an outlet capable of releasing the pressurized product as a foam, wherein the pressurized product comprises a foamable composition including: an antibiotic agent; at least one organic carrier selected from the group consisting of a hydrophobic organic carrier, an organic polar solvent, an emollient and mixtures thereof, at a concentration of about 2% to about 50% by weight, a surface-active agent, about 0.01% to about 5% by weight of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent, water; and liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.
-
Citations
97 Claims
-
1. A method of treating or alleviating disorders of a skin, body cavity or mucosal surface, wherein the disorder involves inflammation as one of its etiological factors, the method comprising:
-
a. releasing a foamable composition from an aerosol container to form an expanded thermally stable foam that collapses upon application of mechanical force, said foamable composition comprising a propellant and a composition, said composition comprising; i. an antibiotic agent; ii. a therapeutically active oil comprising about 10% to about 50% by weight of the composition of a capric/caprylic triglyceride; iii. a surface-active agent; iv. about 0.01% to about 5% by weight of the composition of at least one polymeric additive selected from the group consisting of a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent; and v. water; wherein the propellant comprises a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the foamable composition b. administering the foam to a target area having a disorder of the skin, body cavity or mucosa; and c. collapsing the foam by applying mechanical force, wherein the foam is absorbed onto the target area, wherein the antibiotic agent is administered in a therapeutically effective amount; wherein the composition contains less than 5% by weight of the composition of short chain alcohols having up to 5 carbon atoms in their carbon chain skeleton and one hydroxyl group; and wherein the composition is a thermally stable breakable foam. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 78, 79)
-
-
58. A method of treating or alleviating disorders of a skin, body cavity or mucosal surface, wherein the disorder involves inflammation as one of its etiological factors, the method comprising:
-
a. releasing a foamable composition from an aerosol container to form an expanded thermally stable foam that collapses upon application of mechanical force, said foamable composition comprising a propellant and a composition, said composition comprising; (i) an antibiotic agent; (ii) about 2% to about 50% by weight of the composition of at least one hydrophobic organic carrier comprising a polypropylene glycol alkyl ether; (iii) a therapeutically active oil comprising about 10% to about 50% by weight of the composition of a capric/caprylic triglyceride (iv) a surface-active agent; (v) about 0.01% to about 5% by weight of the composition of a polymeric additive selected from a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent; and (vi) water, b. administering the foam to a target area having a disorder of the skin, body cavity or mucosa; and c. collapsing the foam by applying mechanical force, wherein the foam is absorbed onto the target area, wherein the antibiotic agent is administered in a therapeutically effective amount; wherein the foamed composition contains less than 5% by weight of the composition of short chain alcohols having up to 5 carbon atoms in their carbon chain skeleton and one hydroxyl group; and wherein the foamed composition is a thermally stable breakable foam. - View Dependent Claims (59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91)
-
-
92. A method of treating or alleviating disorders of a skin, body cavity or mucosal surface, wherein the disorder involves inflammation as one of its etiological factors, the method comprising:
-
a. releasing a foamable composition from an aerosol container to form an expanded thermally stable foam that collapses upon application of mechanical force, said foamable composition comprising a propellant and a composition, said composition comprising; (i) an antibiotic agent; (ii) at least one organic carrier selected from a hydrophobic organic carrier, a polar solvent, an emollient, or mixtures thereof, at a concentration of about 2% to about 50% by weight of the composition; (iii) a therapeutically active oil comprising about 10% to about 50% by weight of the composition of a capric/caprylic triglyceride; (iv) a surface-active agent; (v) about 0.01% to about 5% by weight of the composition of a polymeric additive selected from the group consisting of;
a locust bean gum, a gelatin agar, a xanthan gum, a quince seed extract, a tragacanth gum, a guar gum, a starch, a chemically modified starch, a cellulose ether, an alkyl cellulose polymer, a hydroxyalkyl cellulose polymer, a hydroxypropyl guar gum, a soluble starch, a chitosan, a polyvinylpyrrolidone, a polyvinyl alcohol, a polyacrylic acid polymer, a polymethacrylic acid polymer, a polyvinyl acetate polymer, a polyvinyl chloride polymer, a polyvinylidene chloride polymer, silicone dioxide, and mixtures of two or more thereof; and(vi) water, b. administering the foam to a target area having a disorder of the skin, body cavity or mucosa; and c. collapsing the foam by applying mechanical force, wherein the foam is absorbed onto the target area, wherein the antibiotic agent is administered in a therapeutically effective amount; wherein the foamed composition contains less than 5% by weight of the composition of short chain alcohols having up to 5 carbon atoms in their carbon chain skeleton and one hydroxyl group; and wherein the foamed composition is a thermally stable breakable foam. - View Dependent Claims (93, 94, 95, 96, 97)
-
Specification